Forxiga HF General Drug Use-Results Study

Trial Identifier:	D1699C00017
Sponsor:	AstraZeneca
Start Date:	May 2021
Primary Completion Date:	August 2024
Study Completion Date:	August 2024
Condition:	Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Fukushima, Japan
Japan	Kochi, Japan
Japan	Toyama, Japan
Japan	Yamagata, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.